Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.47 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL140667 | 1.00 | LMNA (0.53) | LMNAHTTALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL30542253 | 0.84 | SMN1; SMN2 (0.49) | LMNAHTTALDH1A1SMN1; SMN2CYP2C19 | |
| SCHEMBL145336 | 0.84 | SMN1; SMN2 (0.49) | LMNAHTTALDH1A1SMN1; SMN2CYP2C19 | |
| SCHEMBL5814377 | 0.82 | HTT (0.54) | LMNAHTTALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL5525050 | 0.81 | SIGMAR1 (0.50) | LMNAALDH1A1KDM4EMAPTL3MBTL1 | |
| SCHEMBL28880172 | 0.81 | L3MBTL1 (0.56) | LMNAALDH1A1SMN1; SMN2NPC1CYP2C19 | |
| SCHEMBL6833378 | 0.81 | POLB (0.51) | ALDH1A1NPC1MAPTKMT2A | |
| SCHEMBL29586280 | 0.81 | GAA (0.53) | LMNAHTTALDH1A1KDM4EMAPT | |
| SCHEMBL28563284 | 0.81 | LMNA (0.58) | LMNAHTTALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL24356073 | 0.80 | HTT (0.56) | LMNAHTTALDH1A1SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118704008-A | Copper etching solution for packaging circuit substrate and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-114432901-B | Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof | 中国石油化工股份有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-114432901-A | Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof | 中国石油化工股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-118704008-A | Copper etching solution for packaging circuit substrate and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-114249702-B | N-aryl- [2,4 '-dithiazole ] -2' -amine compound and preparation and application thereof | 沈阳药科大学 | 2023-09-05 | — | — | CN | disclosed |
| CN-114432901-B | Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof | 中国石油化工股份有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20220402881-A1 | SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS | ALBERT EINSTEIN COLLEGE OF MEDICINE | 2022-12-22 | — | — | US | disclosed |
| CN-115135697-A | Process for producing polythioether compound | 株式会社大赛璐 | 2022-09-30 | — | — | CN | disclosed |
| EP-4054608-A1 | SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS | Albert Einstein College of Medicine (US) | 2022-09-14 | — | — | EP | disclosed |
| CN-114432901-A | Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof | 中国石油化工股份有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-114249702-A | N-aryl- [2,4 '-bithiazole ] -2' -amine compound and preparation and application thereof | 沈阳药科大学 | 2022-03-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402881-A1 | SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS | PTGER1, PTGIS, PTGIR | LMNA 2850/4885HTT 3322/4885ALDH1A1 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.